Jack Weinstein joined Relief in October 2020 as its U.S. based Chief Financial Officer and Treasurer. He brings over 40 years of wide-ranging executive management expertise, including as a CFO, investment banker and consultant in the biopharmaceutical and life sciences industries. Jack has extensive experience in finance and healthcare investment banking, corporate and business development as well as FDA regulatory and intellectual property strategies. He has successfully completed a variety of corporate finance transactions, including public and private financings, as well as merger and acquisition transactions. Before joining Relief, Jack served as Managing Director and Head of Healthcare Investment Banking at Avalon NetWorth, an independent New York-based boutique investment bank. Prior to Avalon, he was CFO, Treasurer and Vice President of Business Development at Catalyst Pharmaceuticals, Inc., a biopharmaceutical company developing prescription pharmaceutical products to treat orphan diseases. Jack eventually took the company public through a full-blown IPO on the Nasdaq Global Market. He also was President and Founder of The Sterlington Group, Inc. a consulting firm providing strategic, business development, regulatory and “CFO” consulting services, including M&A advisory and raising equity and debt for middle-market companies. Adding to his credentials, Jack gained experience at several other investment banking and consulting firms. He holds an MBA from Harvard University.